Literature DB >> 15719382

Multiple endocrine neoplasia type 1.

Gerard M Doherty1.   

Abstract

Multiple endocrine neoplasia-1 (MEN-1) is an autosomal dominant inherited syndrome that occurs due to inactivating mutations of the MEN1 gene locus, coding for a tumor-suppressor protein, menin. The components of MEN-1 are hyperparathyroidism due to multiple parathyroid adenomas, pancreatic neuroendocrine tumors, and pituitary adenomas, in addition to some less common neoplastic manifestations. Care of people with MEN-1 requires knowledge of the problems that may arise, and the best approaches to detect and care for the manifestations of this incurable, but manageable, disease. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719382     DOI: 10.1002/jso.20181

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.

Authors:  D M Pritchard
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

2.  Familiality in brain tumors.

Authors:  Deborah T Blumenthal; Lisa A Cannon-Albright
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

3.  Intracranial ependymoma associated with multiple endocrine neoplasia type 1.

Authors:  A Al-Salameh; P François; S Giraud; A Calender; A-M Bergemer-Fouquet; L de Calan; P Goudet; P Lecomte
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

4.  The surgical management of pancreaticoduodenal tumours in multiple endocrine neoplasia type 1.

Authors:  Sri G Thrumurthy; Ravindra S Date; Muntzer M Mughal; Kishore G Pursnani; Jeremy B Ward
Journal:  BMJ Case Rep       Date:  2009-04-14

5.  A case of multiple endocrine neoplasia type 1 with primary liver gastrinoma.

Authors:  Sul Ra Lee; Moon Chan Choi; Kyu Jeung Ahn
Journal:  J Korean Med Sci       Date:  2010-05-25       Impact factor: 2.153

6.  Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1).

Authors:  Takamasa Nishiuchi; Hitomi Imachi; Koji Murao; Mako Fujiwara; Tomie Muraoka; Fumi Kikuchi; Yukiko Nishiuchi; Yoshio Kushida; Reiji Haba; Toshihiko Ishida
Journal:  Endocrine       Date:  2009-04-07       Impact factor: 3.633

7.  The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis.

Authors:  F Marini; S Carbonell Sala; A Falchetti; D Caramelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 8.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

9.  Multiple endocrine neoplasia type 1 with multiple leiomyomas linked to a novel mutation in the MEN1 gene.

Authors:  Heekyoung Choi; Sehyun Kim; Jae-Hoon Moon; Yoon Hee Lee; Yumie Rhee; Eun Seok Kang; Chul Woo Ahn; Bong Soo Cha; Eun Jig Lee; Kyung Rae Kim; Hyun Chul Lee; Seon Yong Jeong; Hyun Ju Kim; Sung-Kil Lim
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

10.  Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration.

Authors:  Hiroyuki Tamiya; Megumi Miyakawa; Akira Takeshita; Daishu Miura; Yasuhiro Takeuchi
Journal:  J Bone Miner Metab       Date:  2014-09-17       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.